1. Home
  2. COMP vs KRYS Comparison

COMP vs KRYS Comparison

Compare COMP & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Inc.

COMP

Compass Inc.

HOLD

Current Price

$11.39

Market Cap

8.8B

Sector

Technology

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$341.12

Market Cap

10.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COMP
KRYS
Founded
2012
2015
Country
United States
United States
Employees
N/A
295
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
10.1B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
COMP
KRYS
Price
$11.39
$341.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
11
Target Price
$11.80
$297.60
AVG Volume (30 Days)
12.3M
548.4K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
67.74
128.00
EPS
0.03
1.83
Revenue
$6,961,600,000.00
$389,130,000.00
Revenue This Year
$90.43
$38.74
Revenue Next Year
$8.63
$32.53
P/E Ratio
$382.83
$199.26
Revenue Growth
23.67
33.94
52 Week Low
$6.37
$130.50
52 Week High
$13.96
$382.54

Technical Indicators

Market Signals
Indicator
COMP
KRYS
Relative Strength Index (RSI) 50.59 48.69
Support Level $11.08 $246.17
Resistance Level $13.16 $382.33
Average True Range (ATR) 0.57 18.24
MACD -0.15 -0.46
Stochastic Oscillator 34.58 53.10

Price Performance

Historical Comparison
COMP
KRYS

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: